Coexpression of Helios in Foxp3+ Regulatory T Cells and Its Role in Human Disease
- PMID: 34257746
- PMCID: PMC8245237
- DOI: 10.1155/2021/5574472
Coexpression of Helios in Foxp3+ Regulatory T Cells and Its Role in Human Disease
Abstract
Regulatory T cells (Tregs) expressing the Foxp3 transcription factor are indispensable for the maintenance of immune system homeostasis. Tregs may lose Foxp3 expression or be reprogrammed into cells that produce proinflammatory cytokines, for example, Th1-like Tregs, Th2-like Tregs, Th17-like Tregs, and Tfh-like Tregs. Accordingly, selective therapeutic molecules that manipulate Treg lineage stability and/or functional activity might have the potential to improve aberrant immune responses in human disorders. In particular, the transcription factor Helios has emerged as an important marker and modulator of Tregs. Therefore, the current review focuses on recent findings on the expression, function, and mechanisms of Helios, as well as the patterns of Foxp3+ Tregs coexpressing Helios in various human disorders, in order to explore the potential of Helios for the improvement of many immune-related diseases. The studies were selected from PubMed using the library of the Nanjing Medical University in this review. The findings of the included studies indicate that Helios expression stabilizes the phenotype and function of Foxp3+ Tregs in certain inflammatory environments. Further, Tregs coexpressing Helios and Foxp3 were identified as a specific phenotype of stronger suppressor immune cells in both humans and animal models. Importantly, there is ample evidence that Helios-expressing Foxp3+ Tregs are relevant to various human disorders, including connective tissue diseases, infectious diseases, solid organ transplantation-related immunity, and cancer. Thus, Helios+Foxp3+CD4+ Tregs could be a valuable _target in human diseases, and their potential should be explored further in the clinical setting.
Copyright © 2021 Wen-qing Yu et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Similar articles
-
FOXP3+Helios+ Regulatory T Cells, Immune Activation, and Advancing Disease in HIV-Infected Children.J Acquir Immune Defic Syndr. 2016 Aug 15;72(5):474-84. doi: 10.1097/QAI.0000000000001000. J Acquir Immune Defic Syndr. 2016. PMID: 27003495 Free PMC article.
-
Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP.Onco_target. 2015 Aug 21;6(24):20026-36. doi: 10.18632/onco_target.4771. Onco_target. 2015. PMID: 26343373 Free PMC article.
-
Helios+ and Helios- cells coexist within the natural FOXP3+ T regulatory cell subset in humans.J Immunol. 2013 Mar 1;190(5):2001-8. doi: 10.4049/jimmunol.1201379. Epub 2013 Jan 28. J Immunol. 2013. PMID: 23359504
-
Helios: still behind the clouds.Immunology. 2019 Nov;158(3):161-170. doi: 10.1111/imm.13115. Epub 2019 Oct 13. Immunology. 2019. PMID: 31517385 Free PMC article. Review.
-
Defining Human Regulatory T Cells beyond FOXP3: The Need to Combine Phenotype with Function.Cells. 2024 May 30;13(11):941. doi: 10.3390/cells13110941. Cells. 2024. PMID: 38891073 Free PMC article. Review.
Cited by
-
Comparative effects of hepatocyte growth factor and tacrolimus on acute liver allograft early tolerance.Front Immunol. 2023 Aug 8;14:1162439. doi: 10.3389/fimmu.2023.1162439. eCollection 2023. Front Immunol. 2023. PMID: 37614233 Free PMC article.
-
CARs: a new approach for the treatment of autoimmune diseases.Sci China Life Sci. 2023 Apr;66(4):711-728. doi: 10.1007/s11427-022-2212-5. Epub 2022 Nov 4. Sci China Life Sci. 2023. PMID: 36346550 Free PMC article. Review.
-
Modulation of Suppressive Activity and Proliferation of Human Regulatory T Cells by Splice-Switching Oligonucleotides _targeting FoxP3 Pre-mRNA.Cells. 2023 Dec 29;13(1):77. doi: 10.3390/cells13010077. Cells. 2023. PMID: 38201281 Free PMC article.
-
Correlations between Circulating and Tumor-Infiltrating CD4+ Treg Subsets with Immune Checkpoints in Colorectal Cancer Patients with Early and Advanced Stages.Vaccines (Basel). 2022 Sep 5;10(9):1471. doi: 10.3390/vaccines10091471. Vaccines (Basel). 2022. PMID: 36146549 Free PMC article.
-
Helios as a Potential Biomarker in Systemic Lupus Erythematosus and New Therapies Based on Immunosuppressive Cells.Int J Mol Sci. 2023 Dec 29;25(1):452. doi: 10.3390/ijms25010452. Int J Mol Sci. 2023. PMID: 38203623 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials